Lungscape: Resected Non–Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters-Reference-Cited by-同舟云学术

Lungscape: Resected Non–Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters

Published:2014-11 Issue:11 Volume:9 Page:1675-1684
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Peters Solange,Weder Walter,Dafni Urania,Kerr Keith M.,Bubendorf Lukas,Meldgaard Peter,O’Byrne Kenneth J.,Wrona Anna,Vansteenkiste Johan,Felip Enriqueta,Marchetti Antonio,Savic Spasenija,Lu Shun,Smit Egbert,Dingemans Anne-Marie,Blackhall Fiona H.,Baas Paul,Camps Carlos,Rosell Rafael,Stahel Rolf A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Group NM-aC. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data;Arriagada;Lancet,2010

2. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

3. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011

4. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities;Perez-Moreno;Clin Cancer Res,2012

5. A class of K-sample tests for comparing the cumulative incidence of a competing risk;Gray;Ann Stat,1988

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Staging by Thoracoscopy in potentially radically treatable Lung Cancer associated with Minimal Pleural Effusion (STRATIFY): protocol of a prospective, multicentre, observational study;BMJ Open Respiratory Research;2023-11

2. Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC;New England Journal of Medicine;2023-07-13

3. A Graph-Based Approach to Identify Factors Contributing to Postoperative Lung Cancer Recurrence among Patients with Non-Small-Cell Lung Cancer;Cancers;2023-07-03

4. Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2;Clinical Lung Cancer;2023-06

5. CT-derived body composition associated with lung cancer recurrence after surgery;Lung Cancer;2023-05